about
Biomaterial-based technologies for brain anti-cancer therapeutics and imaging.The use of topical corticosteroides in the treatment of oral lichen planus in Spain: A national surveySystematic review and meta-analysis of the efficacy and safety of alendronate and zoledronate for the treatment of postmenopausal osteoporosis.Intranasal delivery of plasma and platelet growth factors using PRGF-Endoret system enhances neurogenesis in a mouse model of Alzheimer's disease.Frequency of obstructive sleep apnea syndrome in dental patients with tooth wearLeukocyte inclusion within a platelet rich plasma-derived fibrin scaffold stimulates a more pro-inflammatory environment and alters fibrin propertiesNontraumatic Implant Explantation: A Biomechanical and Biological Analysis in Sheep Tibia.Efficacy of mandibular advancement device in the treatment of obstructive sleep apnea syndrome: A randomized controlled crossover clinical trial.Growth and trophic factors, pH and the Na+/H+ exchanger in Alzheimer's disease, other neurodegenerative diseases and cancer: new therapeutic possibilities and potential dangers.The potential impact of the preparation rich in growth factors (PRGF) in different medical fields.Delivering growth factors for therapeutics.Platelet-rich therapies in the treatment of orthopaedic sport injuries.Biomaterials for promoting brain protection, repair and regeneration.Potential of endogenous regenerative technology for in situ regenerative medicine.The future: optimizing the healing environment in anterior cruciate ligament reconstruction.Platelet-rich plasma to improve the bio-functionality of biomaterials.Endogenous morphogens and fibrin bioscaffolds for stem cell therapeutics.A biological therapy to osteoarthritis treatment using platelet-rich plasma.Safety and efficient ex vivo expansion of stem cells using platelet-rich plasma technology.Efficacy and safety of plasma rich in growth factors intra-articular infiltrations in the treatment of knee osteoarthritis.Platelet rich plasma and knee surgery.Autologous serum and plasma rich in growth factors in ophthalmology: preclinical and clinical studies.Effectiveness and efficiency of platelet rich plasma in the treatment of diabetic ulcers.Immediate Loading of Short Implants in Posterior Maxillae: Case Series.Progress in the Use of Autologous Regenerative Platelet-based Therapies in Implant Dentistry.Plasma Rich in Growth Factors for the Treatment of Ocular Surface Diseases.Treatment of patients with neurotrophic keratitis stages 2 and 3 with plasma rich in growth factors (PRGF-Endoret) eye-drops.Biological effects of plasma rich in growth factors (PRGF) on human endometrial fibroblasts.A new strategy to tackle severe knee osteoarthritis: Combination of intra-articular and intraosseous injections of Platelet Rich Plasma.Opening new horizons in regenerative dermatology using platelet-based autologous therapies.Healing or Not Healing.Transalveolar Osteotomy of the Mandibular Canal Wall for the Treatment of Severely Atrophied Posterior Mandible.Effects of calcium ions on titanium surfaces for bone regeneration.Intranasal PRGF-Endoret enhances neuronal survival and attenuates NF-κB-dependent inflammation process in a mouse model of Parkinson's disease.Personalized plasma-based medicine to treat age-related diseases.PRGF exerts more potent proliferative and anti-inflammatory effects than autologous serum on a cell culture inflammatory model.Minimizing the mandibular advancement in an oral appliance for the treatment of obstructive sleep apnea.The Effect of Plasma Rich in Growth Factors on Pattern Hair Loss: A Pilot Study.Cellular acidification as a new approach to cancer treatment and to the understanding and therapeutics of neurodegenerative diseases.Platelet-rich plasma, a source of autologous growth factors and biomimetic scaffold for peripheral nerve regeneration.
P50
Q33560592-3B7DC9D9-E33F-4807-83CB-5799C0DB60BFQ33688007-37E4C7AE-A5F2-47BE-AE73-6CBE788DE84CQ34373101-7EBC9C4C-0A4C-4539-A584-146776DC9DFCQ34998572-5AB247C0-5A7F-482C-BDEB-CA5A4069954FQ35193840-C7375EF9-96E5-4D5A-B67A-89BE5455118FQ35231485-04A8CF4C-B0CB-42EB-9150-2F3A51952D65Q35533266-FA4AA6D7-911A-4D1F-9AEF-9C4EB2B22B9AQ36139614-DB8E9BB0-B3D5-4B32-9695-4248F710DE02Q36742439-563ADD60-1C74-4ACB-AB59-D1DADD66E418Q36894816-38996A9F-FF62-41F8-8C4D-E3BFF9D17988Q37013728-FAA07EFF-820E-4212-A67F-AD0ECEA48575Q37464139-82BCCB05-ABBC-45DF-8F5C-E994D32EE560Q37572357-002F631A-6FBE-4C9A-A164-8CFA5E1BD240Q37681695-8EAD9B18-3F59-450F-BDAB-1BC34EE7070FQ37693649-04AAC341-FE12-47DF-886F-84363BBAD518Q38074883-5A9F1123-3FBB-4AAD-98F8-6BEE95132439Q38104142-39C5390E-4B0D-48DC-B64C-37103A524B8EQ38120027-1D01502F-90AA-4904-91D0-1C7E8961666DQ38136243-8ABAA26E-A8ED-4924-A19B-B11D1B7881DEQ38226492-8B98A680-DF91-4509-9DCB-57DBE6FDB108Q38258771-D84B5BD8-99E5-4052-AD3C-7B207B8E996CQ38400516-53605E65-9995-4F0B-B7D8-6C89932AFF02Q38454830-63EA11BC-20DB-492A-A38E-9A5372D912FDQ38615154-66015EB0-EA99-4106-812B-303663A59594Q38712483-D982DCC9-C327-45EF-9A10-B502E44855D8Q38717416-9D45FFA8-4D1E-4D72-A28E-CA3C2C8712DEQ38723051-58BDC1B9-CC7D-4168-B93C-9A917CF9C1A8Q38742889-9DA9024F-1790-4C2E-A46F-0787E4EA4909Q38756291-11C5B019-C92D-4586-931D-14FB143396ADQ38759506-306F2324-3B7E-4E64-98A6-8F095AC214D4Q38765916-01A85554-3ED2-4462-B7DA-06E9CD1A0933Q38847805-4CABAA3E-EBE3-45BF-999D-CFFA33F5A174Q38885646-5AA9B647-604B-4296-8977-9DDB48F84583Q38907299-CEB02792-128B-427D-8E59-3A36514A0882Q38932649-D03BDE75-8492-44F3-B602-2786DAAC119DQ38938839-7CEF5215-3F76-4C95-AC4D-B16A9EBA818BQ38947641-16E91E12-918B-4042-A9CE-33F244EE88FEQ38950470-4C9D5741-3BB0-48B1-B15B-93519E15DC1BQ38963473-4F486FE4-1A8F-4F02-A25D-C759E4D46A12Q39009135-94AF48CF-A798-4C04-9FB9-138019343E5C
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Eduardo Anitua
@ast
Eduardo Anitua
@en
Eduardo Anitua
@es
Eduardo Anitua
@nl
type
label
Eduardo Anitua
@ast
Eduardo Anitua
@en
Eduardo Anitua
@es
Eduardo Anitua
@nl
prefLabel
Eduardo Anitua
@ast
Eduardo Anitua
@en
Eduardo Anitua
@es
Eduardo Anitua
@nl
P106
P1153
55896953500
P21
P31
P496
0000-0002-8386-5303